Ensysce Biosciences
(NASDAQ) ENSC
Ensysce Biosciences Financials at a Glance
Market Cap
$2.09M
Revenue (TTM)
$4.49M
Net Income (TTM)
$10.97M
EPS (TTM)
$-6.10
P/E Ratio
-0.09
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.54
Volume
3,718
Open
$0.59
Price
$0.54
Volume
3,718
Open
$0.59
Previous Close
$0.57
Daily Range
$0.53 - $0.59
52-Week Range
$0.31 - $4.85
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.54
Volume
3,718
Open
$0.59
Previous Close
$0.57
Daily Range
$0.53 - $0.59
52-Week Range
$0.31 - $4.85
ENSC News
ENSC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ensysce Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
D. Lynn Kirkpatrick, PhD
Website
www.ensysce.comHeadquarters
La Jolla, CA 92037, US
ENSC Financials
Key Financial Metrics (TTM)
Gross Margin
-93%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-271%
Return on Capital
-13%
Return on Assets
-3%
Earnings Yield
-11.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.09M
Shares Outstanding
3.63M
Volume
3.72K
Short Interest
0.00%
Avg. Volume
6.19M
Financials (TTM)
Gross Profit
$2.01M
Operating Income
$6.73M
EBITDA
$6.73M
Operating Cash Flow
$7.50T
Capital Expenditure
$0.00
Free Cash Flow
$7.50T
Cash & ST Invst.
$3.50M
Total Debt
$301.66K
Ensysce Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$493.10K
-85.6%
Gross Profit
$2.46M
-242.5%
Gross Margin
-4.99%
N/A
Market Cap
$2.09M
N/A
Market Cap/Employee
$298.37K
N/A
Employees
7
N/A
Net Income
$3.73M
-663.5%
EBITDA
$18.34K
-97.2%
Quarterly Fundamentals
Net Cash
$1.31M
-65.2%
Accounts Receivable
$4.41K
-99.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$364.07K
-6.0%
Return on Assets
-3.45%
N/A
Return on Invested Capital
-12.62%
N/A
Free Cash Flow
$1.99M
-95.0%
Operating Cash Flow
$1.87M
-82.9%